Literature DB >> 2641792

Behavioral effects of yohimbine and chlordiazepoxide: dependence on the rat's previous familiarization with the test conditions.

C Gentsch1, M Lichteiner, H Feer.   

Abstract

The effects of yohimbine and chlordiazepoxide on locomotor activity in an open field were found to depend on the rat's previous habituation to the test environment: chlordiazepoxide induced a locomotor activation in nonhabituated, but not in habituated rats; yohimbine activated in habituated rats only. In a further study, carried out in the rat's homecage (habituated conditions), the effect of both drugs on competition for sucrose pellets was assessed: yohimbine, but not chlordiazepoxide, helped so-called poor-performing rats to temporarily overcome their typical abstention from competition. The presence or absence of drug effects, obviously depending on the rat's previous familiarization with the test environment, are discussed with view to Gray's concept of the behavioral inhibition system.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2641792     DOI: 10.1159/000118601

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  3 in total

1.  The effect of alpha 2 adrenoceptor blockers on aggressive behavior in mice: implications for the actions of adrenoceptor agents.

Authors:  J Haller; G B Makara; J L Kovács
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

2.  Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats.

Authors:  Stephanie L Grella; Douglas Funk; Kathy Coen; Zhaoxia Li; A D Lê
Journal:  Behav Brain Res       Date:  2014-02-28       Impact factor: 3.332

3.  Utilization of palliative care in patients hospitalized with heart failure: A contemporary national perspective.

Authors:  Fahad Alqahtani; Sudarshan Balla; Ahmad Almustafa; George Sokos; Mohamad Alkhouli
Journal:  Clin Cardiol       Date:  2018-12-15       Impact factor: 2.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.